What Researchers Did
Researchers reviewed current combination drug therapies used to fight infections caused by bacteria that form protective layers called biofilms.
What They Found
The review highlighted that combination drug therapies, including inhaled Fosfomycin/tobramycin, show promise against both Gram-negative and Gram-positive bacteria in biofilms. It also noted that hyperbaric oxygen treatment (HBOT) could improve the effectiveness of fluoroquinolone antibiotics against biofilms by counteracting low oxygen levels within the biofilm matrix. Additionally, adjuvants like Ethylenediaminetetraacetic acid (EDTA), Sodium Dodecyl Sulphate (SDS), and chlorhexidine were identified for their ability to kill non-growing microbial cells in biofilms.
What This Means for Canadian Patients
For Canadian patients battling difficult-to-treat bacterial infections, especially those involving medical devices, this review suggests that combining different drugs could offer more effective treatment options. The potential for hyperbaric oxygen therapy to boost antibiotic action against biofilms could lead to improved outcomes for persistent infections.
Canadian Relevance
No direct Canadian connection identified. However, the study covers the general challenge of antimicrobial resistance and difficult-to-treat infections, which is a global health concern relevant to patient care in Canada.
Study Limitations
As a review, this study summarizes existing literature and does not present new experimental data or specific optimized HBOT protocols.